| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 142 | 100 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | 5.038 | 5.696 | 12.852 | 5.379 | 456 | 14.482 | 1.522 |
| Total Expenses - EUR | - | - | - | 14.200 | 28.618 | 15.737 | 7.864 | 4.099 | 4.282 | 5.278 |
| Gross Profit/Loss - EUR | - | - | - | -9.162 | -22.922 | -2.885 | -2.485 | -3.643 | 10.200 | -3.756 |
| Net Profit/Loss - EUR | - | - | - | -9.162 | -22.922 | -2.887 | -2.486 | -3.643 | 8.569 | -3.756 |
| Employees | - | - | - | 2 | 2 | 2 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Terra Sun Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 39.266 | 30.442 | 25.162 | 20.517 | 16.482 | 12.345 | 8.058 |
| Current Assets | - | - | - | 2.786 | 3.358 | 8.777 | 10.337 | 9.740 | 13.724 | 5 |
| Inventories | - | - | - | 1.880 | 3.186 | 7.829 | 7.474 | 7.497 | 7.474 | 0 |
| Receivables | - | - | - | 0 | 68 | 126 | 94 | 94 | 94 | 0 |
| Cash | - | - | - | 906 | 103 | 822 | 2.769 | 2.149 | 6.156 | 5 |
| Shareholders Funds | - | - | - | -10.428 | -32.814 | -35.079 | -36.787 | -40.544 | -31.852 | -35.430 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 14.613 | 35.173 | 43.757 | 48.403 | 47.924 | 49.605 | 43.493 |
| Income in Advance | - | - | - | 37.867 | 31.441 | 25.260 | 19.238 | 18.842 | 8.316 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1089 - 1089" | |||||||||
| CAEN Financial Year |
1089
|
|||||||||
Comments - Terra Sun Pharm S.r.l.